Research Article

Association of Maternal Creatinine-to-Body Weight and Urea-to-Creatinine Ratios with Gestational Diabetes Mellitus

Volume: 12 Number: 3 March 1, 2026

Association of Maternal Creatinine-to-Body Weight and Urea-to-Creatinine Ratios with Gestational Diabetes Mellitus

Abstract

Objectives: Gestational diabetes mellitus (GDM) is a multifactorial metabolic disorder associated with altered glucose metabolism and systemic physiological adaptations during pregnancy. Subtle changes in renal-related biochemical parameters may reflect underlying metabolic alterations accompanying GDM. This study aimed to evaluate the association between maternal creatinine-to-body weight (Cre/BW) and urea-to-creatinine (Urea/Cre) ratios and GDM, with a particular focus on their potential role as renal–metabolic indicators during pregnancy.

Methods: This retrospective case–control study included 1,064 pregnant women (532 with GDM and 532 matched controls) who underwent a 75 g oral glucose tolerance test between 24 and 28 weeks of gestation. Propensity score matching was applied to reduce baseline differences between groups. Maternal serum creatinine, urea, and body weight were recorded in the first and second trimesters, and Cre/BW and Urea/Cre ratios were calculated. Group comparisons, receiver operating characteristic (ROC) analyses, and multivariate logistic regression were performed.

Results: In the second trimester, the Cre/BW ratio was significantly lower, and the Urea/Cre ratio was significantly higher in women with GDM compared with controls (both P<0.001). The Cre/BW ratio demonstrated moderate discriminatory ability for distinguishing GDM status (Area under the curve [AUC]=0.774), whereas the Ure/Cre ratio showed modest performance (AUC=0.614). In multivariate analysis, second-trimester Cre/BW and Urea/Cre ratios remained independently associated with GDM after adjustment for clinically relevant covariates. These results suggest a potential association; however, the discriminatory performance of the Cre/BW and Urea/Cre ratios should be regarded as exploratory rather than diagnostically definitive.

Conclusions: Lower Cre/BW and higher Urea/Cre ratios were associated with GDM in this retrospective cohort. These findings suggest that simple renal-related biochemical ratios may reflect metabolic–renal adaptations in pregnancies complicated by GDM. However, given the modest diagnostic performance and retrospective design, these parameters should be considered exploratory indicators rather than standalone clinical tools. Further prospective studies are required to clarify their clinical relevance.

Keywords

Ethical Statement

This study was approved by the Ankara Etlik City Hospital Scientific Research Evaluation and Ethics Committee (Decision No: AEŞH-BADEK-2024-848; date: 02.10.2024. All procedures were conducted in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments. Informed consent was not required in this study because this is a retrospective study.

References

  1. 1. International Association of Diabetes and Pregnancy Study Groups Consensus Panel; Metzger BE, Gabbe SG, Persson B, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676-682. doi: 10.2337/dc09-1848.
  2. 2. Hod M, Kapur A, Sacks DA, et al. The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: A pragmatic guide for diagnosis, management, and care. Int J Gynaecol Obstet. 2015;131 Suppl 3:S173-211. doi: 10.1016/S0020-7292(15)30033-3.
  3. 3. McIntyre HD, Catalano P, Zhang C, Desoye G, Mathiesen ER, Damm P. Gestational diabetes mellitus. Nat Rev Dis Primers. 2019;5(1):47. doi: 10.1038/s41572-019-0098-8.
  4. 4. Sweeting A, Wong J, Murphy HR, Ross GP. A Clinical Update on Gestational Diabetes Mellitus. Endocr Rev. 2022;43(5):763-793. doi: 10.1210/endrev/bnac003.
  5. 5. Moon JH, Jang HC. Gestational Diabetes Mellitus: Diagnostic Approaches and Maternal-Offspring Complications. Diabetes Metab J. 2022;46(1):3-14. doi: 10.4093/dmj.2021.0335.
  6. 6. Plows JF, Stanley JL, Baker PN, Reynolds CM, Vickers MH. The Pathophysiology of Gestational Diabetes Mellitus. Int J Mol Sci. 2018;19(11):3342. doi: 10.3390/ijms19113342.
  7. 7. Modzelewski R, Stefanowicz-Rutkowska MM, Matuszewski W, Bandurska-Stankiewicz EM. Gestational Diabetes Mellitus-Recent Literature Review. J Clin Med. 2022;11(19):5736. doi: 10.3390/jcm11195736.
  8. 8. Filardi T, Catanzaro G, Mardente S, et al. Non-Coding RNA: Role in Gestational Diabetes Pathophysiology and Complications. Int J Mol Sci. 2020;21(11):4020. doi: 10.3390/ijms21114020.

Details

Primary Language

English

Subjects

Obstetrics and Gynaecology

Journal Section

Research Article

Early Pub Date

February 11, 2026

Publication Date

March 1, 2026

Submission Date

January 5, 2026

Acceptance Date

February 7, 2026

Published in Issue

Year 1970 Volume: 12 Number: 3

AMA
1.Ayas Özkan M, Dayanan R, Duygulu Bulan D, et al. Association of Maternal Creatinine-to-Body Weight and Urea-to-Creatinine Ratios with Gestational Diabetes Mellitus. Eur Res J. 2026;12(3):329-338. doi:10.18621/eurj.1854589